VC firm

ARCH Venture Partners

16 investors · 16 verified

Here are all investors at ARCH Venture Partners.

Investor preview

emails unlock with a plan

Investors on this list. Email addresses unlock with a plan.
namefirmemaillocationverified
Nilay ThakarPrincipalARCH Venture PartnersUnited States1w ago
Scott MinickVenture PartnerARCH Venture PartnersUnited States1w ago
Sean KendallPartnerARCH Venture PartnersUnited States1w ago
Patrick J. EnnisManaging DirectorARCH Venture PartnersUnited States1w ago
Kristina BurowManaging DirectorARCH Venture PartnersUnited States1w ago
Jake BauerVenture PartnerARCH Venture PartnersUnited States3w ago
Joseph JeongVenture PartnerARCH Venture PartnersUnited States3w ago
Corey RitterSenior AssociateARCH Venture PartnersUnited States3w ago
Richard HeymanVenture PartnerARCH Venture PartnersUnited States3w ago
Brett BattlesVenture PartnerARCH Venture PartnersUnited States3w ago
Steven GillisManaging DirectorARCH Venture PartnersUnited States3w ago
Paul BernsManaging DirectorARCH Venture PartnersUnited States4w ago
Keith CrandellManaging DirectorARCH Venture PartnersUnited States4w ago
Carol SuhPartnerARCH Venture PartnersUnited States4w ago
Jay ParrishVenture PartnerARCH Venture PartnersUnited States4w ago
Ari NowacekPrincipalARCH Venture PartnersUnited States4w ago

Browse all VCs

Recent investments at ARCH Venture Partners

  • City TherapeuticsSeries B · $100M · 2026
  • Lightcast DiscoverySeries Unknown · $27M · 2026
  • Salma HealthSeries A · $80M · 2026
  • Syndex BioSeed · $16M · 2026
  • ExcivaSeries B · $62M · 2026
  • Mirador TherapeuticsSeries B · $250M · 2026
  • VizgenSeries E · $48M · 2026
  • Lassen PeakSeries Unknown · $10M · 2026
  • ParadigmSeries B · $78M · 2025
  • SciNeuroSeries Unknown · $53M · 2025
  • YoodliSeries B · $40M · 2025
  • MindImmune TherapeuticsSeries A · $15M · 2025

What founders say

4.1Based on 11 reviews